Report
Rob Hales
EUR 850.00 For Business Accounts Only

Morningstar | UPM Reports In-line Results in 2Q; Shares Fairly Valued

No-moat  UPM-Kymmene  reported second-quarter EBIT of EUR 345 million, a 3% increase over the prior-year period, and in line with consensus. Further, the company maintained 2019 guidance for performance to continue at a good level. This is in stark contrast with major competitor, Stora Enso, which reported a 12% decline in second- quarter EBIT and abandoned its 2019 guidance because of the uncertain economic environment. The key difference between the two companies is UPM’s energy division, which more than doubled EBIT in the second quarter because of materially higher electricity prices. Excluding energy, second-quarter EBIT for the company would have fallen 5%. We continue to expect softer results in second-half 2019 for UPM, particularly in biorefining and communication papers, and therefore don’t expect to make a significant change to our EUR 20 fair value estimate. At current levels, the shares look fairly valued.

Biorefining held up in the second quarter with EBIT increasing 4% over 2018 because of higher volumes and less maintenance downtime. However, global pulp demand has clearly slowed in the first half of the year. We continue to expect deteriorating performance in biorefining in the second half of 2019 because of soft demand from China. EBIT in communication papers fell 10% in the second quarter over 2019. As we discussed in our first-quarter note, we didn’t expect the sharp increase in the segment's first-quarter EBIT to be sustainable. The decline in paper demand has accelerated this year, with demand for graphic papers in Europe falling 9% in the first half and demand for magazine papers in North America falling 13%. Consequently, we expect segment performance to deteriorate further in second-half 2019.
Underlying
UPM-Kymmene Oyj

UPM-Kymmene is a global paper and forest products group, mainly engaged in the production of paper, with an emphasis on the manufacture and sale of printing and writing papers. Co.'s operations comprise of these segments: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Paper Asia, UPM Paper ENA, UPM Plywood and Other. UPM Biocomposites, UPM Biochemicals business units and Group services are reported in Other operations. Co.'s activities are centred in European Union countries, North and South America and Asia with production plants in 13 countries.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Rob Hales

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch